OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie（2019）
摘要
www.ClinicalTrials.Gov (NCT No: NCT02034006).
更多查看译文
关键词
Choroidal neovascularization,Pathologic myopia,Ranibizumab,Retreatment criteria,Visual acuity,Visual impairment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要